Missouri Sen. accuses medical equipment companies of wasteful billing

U.S. Sen. Claire McCaskill claims that companies selling diabetic testing, sleep apnea testing and other durable medical equipment are using misleading and possibly fraudulent sales tactics that end up costing Medicare and Medicaid billions of dollars annually. The Missouri Democrat chairs the new Senate Homeland Security subcommittee on financial and contracting oversight. As the St. Louis Beacon reports, she recently ran the group's first meeting, which focused on related billing complaints. The story notes that the Centers for Medicare and Medicaid Services (CMS) has tried to counter waste issues relating to the matter, but those measures haven't helped much yet, McCaskill said. Story

Suggested Articles

Dexcom received a new European approval for its wearable continuous glucose monitor in pregnant women across Type 1, Type 2 and gestational diabetes.

Infectious disease blood tester Karius has raised $165 million led by SoftBank’s Vision Fund 2, the Japanese conglomerate’s sequel to its VC megafund.

BD will begin working with Babson Diagnostics to help bring its lab-quality device for collecting blood from capillaries into retail pharmacies.